Elekta AB (publ) (EKTAY)
USD 5.07
(0.35%)
USD 5.07
(0.35%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 18.11 Billion SEK | 7.41% |
| 2023 | 16.86 Billion SEK | 15.95% |
| 2022 | 14.54 Billion SEK | 5.7% |
| 2021 | 13.76 Billion SEK | -5.74% |
| 2020 | 14.6 Billion SEK | 7.72% |
| 2019 | 13.55 Billion SEK | 19.61% |
| 2018 | 11.33 Billion SEK | 5.88% |
| 2017 | 10.7 Billion SEK | -4.61% |
| 2016 | 11.22 Billion SEK | 3.52% |
| 2015 | 10.83 Billion SEK | 1.36% |
| 2014 | 10.69 Billion SEK | 3.43% |
| 2013 | 10.33 Billion SEK | 14.27% |
| 2012 | 9.04 Billion SEK | 14.47% |
| 2011 | 7.9 Billion SEK | 6.93% |
| 2010 | 7.39 Billion SEK | 10.51% |
| 2009 | 6.68 Billion SEK | 31.65% |
| 2008 | 5.08 Billion SEK | 12.29% |
| 2007 | 4.52 Billion SEK | 2.35% |
| 2006 | 4.42 Billion SEK | 40.26% |
| 2005 | 3.15 Billion SEK | 8.69% |
| 2004 | 2.9 Billion SEK | 4.28% |
| 2003 | 2.78 Billion SEK | 1.57% |
| 2002 | 2.73 Billion SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.73 Billion SEK | 23.62% |
| 2024 Q4 | 5.02 Billion SEK | 10.71% |
| 2024 Q1 | 3.82 Billion SEK | -25.29% |
| 2024 Q3 | 4.53 Billion SEK | -4.12% |
| 2024 FY | 18.11 Billion SEK | 7.41% |
| 2023 Q1 | 3.32 Billion SEK | -21.51% |
| 2023 Q2 | 4.08 Billion SEK | 22.66% |
| 2023 Q4 | 5.12 Billion SEK | 18.15% |
| 2023 Q3 | 4.33 Billion SEK | 6.27% |
| 2023 FY | 16.86 Billion SEK | 15.95% |
| 2022 Q1 | 3 Billion SEK | -17.94% |
| 2022 Q3 | 3.6 Billion SEK | -2.57% |
| 2022 FY | 14.54 Billion SEK | 5.7% |
| 2022 Q4 | 4.23 Billion SEK | 17.68% |
| 2022 Q2 | 3.69 Billion SEK | 22.86% |
| 2021 Q2 | 3.53 Billion SEK | 18.55% |
| 2021 Q1 | 2.98 Billion SEK | -25.62% |
| 2021 Q4 | 3.66 Billion SEK | 2.4% |
| 2021 Q3 | 3.58 Billion SEK | 1.33% |
| 2021 FY | 13.76 Billion SEK | -5.74% |
| 2020 Q2 | 3.7 Billion SEK | 14.9% |
| 2020 Q4 | 4 Billion SEK | 9.63% |
| 2020 Q1 | 3.22 Billion SEK | -21.02% |
| 2020 Q3 | 3.65 Billion SEK | -1.43% |
| 2020 FY | 14.6 Billion SEK | 7.72% |
| 2019 Q2 | 3.33 Billion SEK | 18.13% |
| 2019 Q4 | 4.08 Billion SEK | 23.1% |
| 2019 Q3 | 3.32 Billion SEK | -0.3% |
| 2019 Q1 | 2.81 Billion SEK | -22.0% |
| 2019 FY | 13.55 Billion SEK | 19.61% |
| 2018 Q2 | 2.8 Billion SEK | 29.18% |
| 2018 FY | 11.33 Billion SEK | 5.88% |
| 2018 Q1 | 2.16 Billion SEK | -41.62% |
| 2018 Q4 | 3.61 Billion SEK | 31.56% |
| 2018 Q3 | 2.74 Billion SEK | -1.96% |
| 2017 Q1 | 1.88 Billion SEK | -47.82% |
| 2017 Q4 | 3.71 Billion SEK | 38.98% |
| 2017 FY | 10.7 Billion SEK | -4.61% |
| 2017 Q3 | 2.67 Billion SEK | 9.82% |
| 2017 Q2 | 2.43 Billion SEK | 29.33% |
| 2016 Q3 | 2.54 Billion SEK | -9.94% |
| 2016 FY | 11.22 Billion SEK | 3.52% |
| 2016 Q1 | 2.23 Billion SEK | -41.92% |
| 2016 Q4 | 3.6 Billion SEK | 41.62% |
| 2016 Q2 | 2.82 Billion SEK | 26.31% |
| 2015 FY | 10.83 Billion SEK | 1.36% |
| 2015 Q4 | 3.85 Billion SEK | 51.06% |
| 2015 Q3 | 2.55 Billion SEK | -0.58% |
| 2015 Q2 | 2.56 Billion SEK | 37.64% |
| 2015 Q1 | 1.86 Billion SEK | -52.83% |
| 2014 Q4 | 3.95 Billion SEK | 65.79% |
| 2014 FY | 10.69 Billion SEK | 3.43% |
| 2014 Q1 | 1.91 Billion SEK | -48.75% |
| 2014 Q2 | 2.44 Billion SEK | 27.77% |
| 2014 Q3 | 2.38 Billion SEK | -2.37% |
| 2013 Q4 | 3.73 Billion SEK | 53.67% |
| 2013 FY | 10.33 Billion SEK | 14.27% |
| 2013 Q1 | 1.69 Billion SEK | -45.66% |
| 2013 Q2 | 2.48 Billion SEK | 46.61% |
| 2013 Q3 | 2.42 Billion SEK | -2.29% |
| 2012 Q1 | 1.42 Billion SEK | -44.57% |
| 2012 Q3 | 2.56 Billion SEK | 32.49% |
| 2012 Q2 | 1.93 Billion SEK | 35.57% |
| 2012 Q4 | 3.11 Billion SEK | 21.6% |
| 2012 FY | 9.04 Billion SEK | 14.47% |
| 2011 Q2 | 1.87 Billion SEK | 15.49% |
| 2011 FY | 7.9 Billion SEK | 6.93% |
| 2011 Q1 | 1.62 Billion SEK | -36.37% |
| 2011 Q3 | 1.82 Billion SEK | -3.03% |
| 2011 Q4 | 2.57 Billion SEK | 41.38% |
| 2010 Q2 | 1.69 Billion SEK | 17.43% |
| 2010 Q1 | 1.44 Billion SEK | 0.0% |
| 2010 Q3 | 1.7 Billion SEK | 0.77% |
| 2010 FY | 7.39 Billion SEK | 10.51% |
| 2010 Q4 | 2.55 Billion SEK | 50.06% |
| 2009 FY | 6.68 Billion SEK | 31.65% |
| 2008 FY | 5.08 Billion SEK | 12.29% |
| 2007 FY | 4.52 Billion SEK | 2.35% |
| 2006 FY | 4.42 Billion SEK | 40.26% |
| 2005 FY | 3.15 Billion SEK | 8.69% |
| 2004 FY | 2.9 Billion SEK | 4.28% |
| 2003 FY | 2.78 Billion SEK | 1.57% |
| 2002 FY | 2.73 Billion SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -567631.399% |
| Ansell Limited | 1.61 Billion USD | -1018.94% |
| Ansell Limited | 1.61 Billion USD | -1018.94% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -9712.752% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -13415915.697% |
| Psykey, Inc. | 419.29 Thousand USD | -4321160.008% |
| ConvaTec Group Plc | 2.19 Billion USD | -725.837% |
| ConvaTec Group Plc | 2.14 Billion USD | -745.734% |
| Encision Inc. | 6.58 Million USD | -275018.807% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -992762.72% |
| LifePoint, Inc. | -18.5 Thousand USD | 97940640.541% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -265847.453% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -2346920.725% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -1837116.848% |
| Reflect Scientific, Inc. | 1.08 Million USD | -1677345.994% |
| SmileDirectClub, Inc. | 470.74 Million USD | -3749.022% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -868.098% |
| SheerVision, Inc. | 3.49 Million USD | -517673.44% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -1306909.913% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -2431676.973% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -17374735.783% |